Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs

Type III interferons (IFNs) (or IFN-λ) are the latest addition to the IFN family. Even though they share little protein homology with type I IFN, both exhibit remarkable functional similarities: each can be induced in response to viral infections, and both lead to Janus kinases (JAK) and signal tran...

Full description

Bibliographic Details
Main Authors: Ivan Zanoni, Francesca Granucci, Achille Broggi
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01661/full
_version_ 1818555598586773504
author Ivan Zanoni
Ivan Zanoni
Francesca Granucci
Achille Broggi
author_facet Ivan Zanoni
Ivan Zanoni
Francesca Granucci
Achille Broggi
author_sort Ivan Zanoni
collection DOAJ
description Type III interferons (IFNs) (or IFN-λ) are the latest addition to the IFN family. Even though they share little protein homology with type I IFN, both exhibit remarkable functional similarities: each can be induced in response to viral infections, and both lead to Janus kinases (JAK) and signal transducer and activator of transcription (STAT) activation. The JAK/STAT pathway induces antiviral responses and IFN-stimulated gene transcription. However, despite the similarities in their effector functions with type I IFNs, IFN-λ also has a non-redundant role in protecting barrier organs: epithelial cells preferentially produce IFN-λ rather than type I IFNs; and interferon lambda receptor 1 (IFNLR1), the specific receptor for IFN-λ, is highly expressed on cells of epithelial lineage. Thus far, IFN-λ has been considered mainly as an epithelial cytokine, which restricts viral replication in epithelial cells and constitutes an added layer of protection at mucosal sites. However, it is now increasingly recognized that IFNLR1 is expressed broadly, and that immune cells such as neutrophils and dendritic cells also respond to IFN-λ. Moreover, in many in vivo models, IFN-λ modulates immune cell functions and thereby configures itself less as a cytokine that is only specific to the epithelium, and more as a cytokine that directly controls the inflammatory response at mucosal sites. Here, we critically review the recent literature on immune modulatory roles for IFN-λ, and distinguish between the direct and indirect effects of this IFN on immune cell functions in different inflammatory settings.
first_indexed 2024-12-12T09:55:32Z
format Article
id doaj.art-50711a1d01e84f198a006991d22d0002
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T09:55:32Z
publishDate 2017-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-50711a1d01e84f198a006991d22d00022022-12-22T00:28:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-11-01810.3389/fimmu.2017.01661319732Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNsIvan Zanoni0Ivan Zanoni1Francesca Granucci2Achille Broggi3Harvard Medical School, Division of Gastroenterology, Boston Children’s Hospital, Boston, MA, United StatesDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, ItalyHarvard Medical School, Division of Gastroenterology, Boston Children’s Hospital, Boston, MA, United StatesType III interferons (IFNs) (or IFN-λ) are the latest addition to the IFN family. Even though they share little protein homology with type I IFN, both exhibit remarkable functional similarities: each can be induced in response to viral infections, and both lead to Janus kinases (JAK) and signal transducer and activator of transcription (STAT) activation. The JAK/STAT pathway induces antiviral responses and IFN-stimulated gene transcription. However, despite the similarities in their effector functions with type I IFNs, IFN-λ also has a non-redundant role in protecting barrier organs: epithelial cells preferentially produce IFN-λ rather than type I IFNs; and interferon lambda receptor 1 (IFNLR1), the specific receptor for IFN-λ, is highly expressed on cells of epithelial lineage. Thus far, IFN-λ has been considered mainly as an epithelial cytokine, which restricts viral replication in epithelial cells and constitutes an added layer of protection at mucosal sites. However, it is now increasingly recognized that IFNLR1 is expressed broadly, and that immune cells such as neutrophils and dendritic cells also respond to IFN-λ. Moreover, in many in vivo models, IFN-λ modulates immune cell functions and thereby configures itself less as a cytokine that is only specific to the epithelium, and more as a cytokine that directly controls the inflammatory response at mucosal sites. Here, we critically review the recent literature on immune modulatory roles for IFN-λ, and distinguish between the direct and indirect effects of this IFN on immune cell functions in different inflammatory settings.http://journal.frontiersin.org/article/10.3389/fimmu.2017.01661/fullinterferon lambdadendritic cellsneutrophilsnatural killer cellstype III interferonviral infection
spellingShingle Ivan Zanoni
Ivan Zanoni
Francesca Granucci
Achille Broggi
Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
Frontiers in Immunology
interferon lambda
dendritic cells
neutrophils
natural killer cells
type III interferon
viral infection
title Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
title_full Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
title_fullStr Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
title_full_unstemmed Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
title_short Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
title_sort interferon ifn λ takes the helm immunomodulatory roles of type iii ifns
topic interferon lambda
dendritic cells
neutrophils
natural killer cells
type III interferon
viral infection
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01661/full
work_keys_str_mv AT ivanzanoni interferonifnltakesthehelmimmunomodulatoryrolesoftypeiiiifns
AT ivanzanoni interferonifnltakesthehelmimmunomodulatoryrolesoftypeiiiifns
AT francescagranucci interferonifnltakesthehelmimmunomodulatoryrolesoftypeiiiifns
AT achillebroggi interferonifnltakesthehelmimmunomodulatoryrolesoftypeiiiifns